Abstract:OBJECTIVE:To explore the effects of transcription factor SOX9 on chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells (hUC-MSCs).METHODS:hUC-MSCs were harvested from human umbilical cord and their phenotypic characteristics identified by flow cytometry. To confirm their multipotency, hUC-MSCs were induced to differentiate toward adiposity and osteogenesis. After transfection with the packaging lentivirus vectors containing SOX9 in vitro, the expression of green fluorescent protein (GFP) and the efficiency of transfection were detected by fluorescence microscopy. Their cellular proliferation capacity was detected by thiazolyl blue tetrazolium bromide (MTT) assay.hUC-MSCs modified with SOX9 were seeded into monolayer and cultured for 21 days in a defined, serum-free medium supplemented with transforming growth factor (TGF)-β1. The untransduced cells or those transduced with GFP served as the controls. Morphologic changes of hUC-MSCs were observed daily and their chondrogenic differentiation was evaluated by reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunofluorescent staining. And the accumulation of sulfated glycosaminoglycans was detected by Alcian blue staining. Meanwhile, the expressions of collagen I, X and cell adhesion molecule N-cadherin were assayed.RESULTS:The hUC-MSCs isolated from human umbilical cord stromas exhibited fibroblastic morphology and they were positive for CD29 (95.9%), CD44 (96.5%), CD90 (98.9%), CD105 (94.3%) and negative for hematopoietic stem cells surface markers CD34 (3.0%) and CD45 (2.6%). At Day 21, hUC-MSCs differentiated toward adiposity and osteogenesis. Both oil red O and alkaline phosphatase stains were intensely positive and it confirmed the multilineage potential of hUC-MSCs. An intense expression of GFP was observed under flourescence microscope and the transfection efficiency of cells with Lenti-GFP-SOX9 or Lenti-GFP was more than 90% respectively. SOX9 gene was over-expressed in hUC-MSCs at 48 h post-transduction. The proliferation of hUC-MSCs had no significant effect after the transfection of lentivirus vectors (P > 0.05). In vitro high-density monolayer culture of these SOX9-transfected hUC-MSCs demonstrated that spontaneous cell aggregation appeared at Day 14 of culturing and subsequently generated large cartilage nodules. However there was no phenomenon of cell aggregation occurring in the cells transducted by Lenti-GFP or untransduced vectors. The expressions of collagen II and Aggrecan were higher in SOX9 transducted cells than those in the controls. Alcian blue staining also showed abundant accumulation of sulfated glycosaminoglycans in the SOX9-induced cartilage nodules. The expression of collagen I had no difference in all groups and collagen X was inhibited in SOX9 transduced cells. N-cadherin was strongly up-regulated by SOX9 and might result in cellular aggregation and formation of large cartilage nodules.CONCLUSION:SOX9 may enhance the chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells through cellular aggregation.

[SOX9 Enhanced Chondrogenic Differentiation Potential of Human Umbilical Cord Mesenchymal Stem Cells Through Cellular Aggregation].

Delivery of the Sox9 Gene Promotes Chondrogenic Differentiation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in an in Vitro Model.

Chondrogenic Differentiation of Human Umbilical Cord Mesenchymal Stem Cells Induced by Sox9

Stage-dependent effect of TGF-beta1 on chondrogenic differentiation of human embryonic stem cells.

Characterization of Sox9-overexpressing Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells-Based Engineered Cartilage Both in Vitro and in Vivo.

Construction of tissue engineered cartilage with Sox9 gene transfection human umbilical cord blood-derived mes-enchymal stem cells and BMG/fibrin

Sox9 Gene Induced Chondrocyte Differentiation of Human Adipose-Derived Stem Cells.

Reduced hypertrophy in vitro after chondrogenic differentiation of adult human mesenchymal stem cells following adenoviral SOX9 gene delivery

The role of Sox9 in collagen hydrogel-mediated chondrogenic differentiation of adult mesenchymal stem cells (MSCs)

Assessment of the expression profile of SRY-type high-mobility-group box-9 during chondrogenesis of mice and the effects of transfection of recombinant rat sty-type high-mobility-group box-9 on mice mesenchymal stem cells in vitro

Co-overexpression of TGF-β and SOX9 Via Raav Gene Transfer Modulates the Metabolic and Chondrogenic Activities of Human Bone Marrow-Derived Mesenchymal Stem Cells.

Chondrogenesis of rabbit mesenchymal stem cells by overexpressing Sox9 gene

Functional Quantum Dot-Sirna Nanoplexes to Regulate Chondrogenic Differentiation of Mesenchymal Stem Cells.

Sox9 Potentiates BMP2-Induced Chondrogenic Differentiation and Inhibits BMP2-Induced Osteogenic Differentiation

Experimental research of SOX9 gene in modifying marrow mesenchymal stem cells and inducing their differentiation toward nucleus pulposus-like cells

Expression of chondrogenic genes during induction of cartilage differentiation of human umbilical cord ;mesenchymal stem cells

Co-expression of BMP2 and Sox9 Promotes Chondrogenic Differentiation of Mesenchymal Stem Cells in Vitro

Exosomes Derived from SOX9 Overexpressing Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Osteoarthritis by Potentially Activating Autophagy

[Biological Characteristics of Mesenchymal Stem Cells in Human Umbilical Cord Blood and Their Supporting Capacities in Ex Vivo Expansion of CD34+ Hematopoietic Stem Cells].

RETRACTED: the Role of Sox9 in Collagen Hydrogel-Mediated Chondrogenic Differentiation of Adult Mesenchymal Stem Cells (mscs) (retracted Article. See MAR, 2023)

Ex Vivo Expansion and Pluripotential Differentiation of Cryopreserved Human Bone Marrow Mesenchymal Stem Cells